PHAXIAM Therapeutics S.A. (EPA:PHXM)

PHAXIAM Therapeutics Revenue

PHAXIAM Therapeutics had revenue of 546.50K EUR in the quarter ending June 30, 2024, with 293.17% growth. This brings the company's revenue in the last twelve months to 2.14M, down -64.15% year-over-year. In the year 2023, PHAXIAM Therapeutics had annual revenue of 1.33M, down -80.05%.

• Revenue (ttm): 2.14M
• Revenue Growth: -64.15%
• P/S Ratio: n/a
• Revenue / Employee: 31.49K
• Employees: 68
• Market Cap: n/a

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	1.33M	-5.32M	-80.05%
Dec 31, 2022	6.65M	2.47M	59.02%
Dec 31, 2021	4.18M	462.00K	12.43%
Dec 31, 2020	3.72M	-1.57M	-29.62%
Dec 31, 2019	5.28M	836.00K	18.80%